CPT code 87582 is a molecular diagnostic laboratory code for quantifying infection with Mycoplasma pneumoniae using a nucleic acid probe technique. This code identifies a specific laboratory procedure that supports diagnosis and management of atypical respiratory infections and is relevant for inpatient and outpatient clinical laboratories nationwide. Molecular detection of Mycoplasma pneumoniae has clinical importance for targeted antimicrobial therapy and infection control.

Key payers addressed in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines how coverage and billing for 87582 are handled across major commercial payers and Medicare, and highlights common clinical contexts in which the test is ordered.

Readers will find benchmarks for utilization and reimbursement patterns, a summary of notable payer coverage practices, and clinical context regarding when nucleic acid probe testing for Mycoplasma pneumoniae is used. The report also describes typical sites of service and the service type for the procedure. Data not available in the input is identified where applicable.